Category: Pharmaceuticals - Page 3

When Doctors Say 'Do Not Substitute': Why Brand Drugs Are Sometimes Required

24Dec
When Doctors Say 'Do Not Substitute': Why Brand Drugs Are Sometimes Required

Doctors write 'Do Not Substitute' on prescriptions when generics could risk patient safety-especially for drugs with narrow therapeutic indexes. Learn when brand drugs are medically necessary, how much more they cost, and what you should ask your doctor.

More

How Generic Drugs Are Reshaping Brand Pharmaceutical Profits

22Dec
How Generic Drugs Are Reshaping Brand Pharmaceutical Profits

Generic drugs save billions annually, but brand manufacturers face revenue cliffs after patent expiry. This article explores how pricing, patent strategies, and middlemen shape the battle between affordable meds and pharmaceutical profits.

More

Respiratory Combination Inhalers: What You Need to Know About Generic Substitution

21Dec
Respiratory Combination Inhalers: What You Need to Know About Generic Substitution

Generic substitution of respiratory combination inhalers can reduce costs-but only if patients are properly trained. Learn why device differences matter more than drug ingredients, and how to avoid dangerous mistakes.

More

Benzodiazepines: Memory Loss, Fall Risks, and How to Taper Safely

19Dec
Benzodiazepines: Memory Loss, Fall Risks, and How to Taper Safely

Benzodiazepines can cause memory loss, increase fall risk in older adults, and lead to dependence. Learn how to taper safely, what to expect after stopping, and why long-term use is no longer recommended.

More

Drug Interactions with Specific Statins: Class Effects and Differences

12Dec
Drug Interactions with Specific Statins: Class Effects and Differences

Different statins have very different risks for drug interactions. Simvastatin and lovastatin are high-risk, while pravastatin and rosuvastatin are safer. Learn which combinations to avoid and how to choose the right statin for your meds.

More

How Multiple Generic Drug Competitors Affect Prices and Market Stability

11Dec
How Multiple Generic Drug Competitors Affect Prices and Market Stability

Multiple generic drug competitors don't always lead to lower prices. Real-world factors like patent strategies, regulatory caps, and pharmacy benefit managers shape market outcomes - sometimes limiting competition despite many approved generics.

More

Citalopram and Escitalopram: QT Prolongation Risks and Safe Dose Limits

5Dec
Citalopram and Escitalopram: QT Prolongation Risks and Safe Dose Limits

Citalopram and escitalopram are effective antidepressants but carry QT prolongation risks that require strict dose limits. Learn the safe dosing guidelines, who’s at risk, and how to minimize cardiac complications.

More

First-Generation Antihistamines: Why Severe Drowsiness and Anticholinergic Effects Matter

4Dec
First-Generation Antihistamines: Why Severe Drowsiness and Anticholinergic Effects Matter

First-generation antihistamines like Benadryl cause severe drowsiness and anticholinergic side effects that can impair cognition, increase dementia risk, and linger for hours. Learn why they're risky-and what to use instead.

More

Machine Learning Signal Detection: How AI Is Revolutionizing Adverse Event Monitoring

25Nov
Machine Learning Signal Detection: How AI Is Revolutionizing Adverse Event Monitoring

Machine learning signal detection is transforming pharmacovigilance by spotting hidden adverse drug reactions faster and more accurately than traditional methods. Using AI on real-world data, it's reducing false alarms and catching dangers before they escalate.

More

Bioequivalence Testing for Generic Drugs: What It Really Proves

24Nov
Bioequivalence Testing for Generic Drugs: What It Really Proves

Bioequivalence testing proves generic drugs work the same as brand-name versions by matching how quickly and how much of the active ingredient enters the bloodstream. It's the science behind affordable medicine.

More